KnocknocSponsored
Hi Citrix. Hide VPNs. Hide Windows on a LAN. Knocknoc solves this. Just in time identity linked allow-listing. DIY, on-premise or SaaS. Prevent attacks fast.
VisitBitdefender GravityZone Small Business Security is a commercial endpoint protection platform solution by Bitdefender. Ivanti Neurons for App Control is a commercial endpoint protection platform solution by Ivanti. Features, integrations, deployment and the company behind each one, side by side.
Endpoint security solution for small businesses with ransomware protection
Application control and privilege management for endpoint security
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
Bitdefender GravityZone Small Business Security fits if you are a startup.
Ivanti Neurons for App Control fits if you are a mid-market company or an enterprise.
Common questions when comparing Bitdefender GravityZone Small Business Security vs Ivanti Neurons for App Control for endpoint protection platform.
Bitdefender GravityZone Small Business Security: Endpoint security solution for small businesses with ransomware protection. Built by Bitdefender.
Ivanti Neurons for App Control: Application control and privilege management for endpoint security. Built by Ivanti.
The table above shows where their features, integrations, deployment and company size fit differ.
Bitdefender GravityZone Small Business Security is made by Bitdefender. Ivanti Neurons for App Control is made by Ivanti. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. Bitdefender GravityZone Small Business Security and Ivanti Neurons for App Control are both Endpoint Protection Platform products, and both cover Ransomware Prevention. Use the table above to see where features, deployment and company size fit differ.
No Endpoint Protection Platform shortlist yet. This is the closest one.
Updated 2026-11-01
See the shortlist
